You just read:

Polynoma Presenting Interim Phase III Data for Its Investigational Melanoma Vaccine, Seviprotimut-L, at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting

News provided by

Polynoma LLC

Nov 06, 2019, 07:00 ET